Search for Clinical Trial Results

Sponsored By

Glaucoma, Neovascular - 24 Studies Found

Status Study
Completed Study Name: Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma
Condition: Glaucoma, Neovascular
Date: 2013-08-04
Interventions: Drug: intravitreal ranibizumab The patients received IVR (0.5 mg in 0.05 ml) injection through the pars
Completed Study Name: Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients
Condition: Glaucoma, Neovascular
Date: 2015-03-18
Interventions:
  • Drug: Aflibercept (Eylea, BAY 86-5321)

Withdrawn Study Name: Effects of Travoprost on Neovascular Glaucoma
Condition: Neovascular Glaucoma
Date: 2007-02-27
Interventions: Drug: Travoprost
Not yet recruiting Study Name: Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study
Condition:
  • Glaucoma, Neovascular
  • Ranibizumab

Date: 2016-09-22
Interventions: Drug: Intravitreal ranibizumab Intravitreal ranibizumab injection
Not yet recruiting Study Name: Comparative Study, Safety and Efficacy, Ahmed Glaucoma Drainage Device, Model M4 Model S2 in Neovascular Glaucoma
Condition: Neovascular Glaucoma
Date: 2014-07-17
Interventions: Procedure: Surgical Implant of Ahmed Glaucoma Drainage Device, model M4 and S2 Surgically Implant an Ahm
Completed Study Name: Avastin as an Adjunct to Diode Laser in the Treatment of Neovascular Glaucoma
Condition: Neovascular Glaucoma
Date: 2010-01-07
Interventions: Procedure: Diode laser cyclophotocoagulation enhanced by intravitreal injection of Avastin The operative
Completed Study Name: Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma
Condition: Neovascular Glaucoma
Date: 2012-10-18
Interventions: Drug: Aflibercept Details covered in arm description
Recruiting Study Name: The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma
Condition: Neovascular Glaucoma
Date: 2017-05-07
Interventions:
  • Procedure: Intracameral injection

Completed Study Name: Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma
Condition:
  • Neovascular Glaucoma
  • Rubeosis

Date: 2011-05-27
Interventions: Drug: 0.5mg intraocular Ranibizumab (Lucentis) short- and long-term effects of 0.5mg intraocular Ranibiz
Withdrawn Study Name: Lucentis for New Onset Neovascular Glaucoma
Condition:
  • Glaucoma
  • New Onset Glaucoma
  • Neovascu
    Date: 2008-07-29
    Interventions: Drug: Ranibizumab (Lucentis) 0.5 mg ranibizumab intravitreal injection single dose administration
Next >>>